All the information you need about JSP PHARMA to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-07-28 | Public | 2021-10-31 | Complete |
| 2021-09-10 | Public | 2020-10-31 | Complete |
| 2020-06-05 | Public | 2019-10-31 | Complete |
| 2019-10-28 | Public | 2018-10-31 | Complete |
| 2018-07-18 | Public | 2017-10-31 | Complete |
| 2017-03-22 | Public | 2016-10-31 | Complete |
| Name | JSP PHARMA |
| Siren | 801959669 |
| Closing | 2018-10-31 |
| Registry code | 6903 |
| Registration number | B2019/005097 |
| Management number | 2018D00180 |
| Activity code | 6420Z |
| Closing date n-1 | 2017-10-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2019-10-28 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 69890 LA TOUR DE SALVAGNY |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BB Receivables related to investments | 82 292.00 | 82 292.00 | 82 292.00 | |
BD Other fixed assets | 54 015.00 | 54 015.00 | 54 015.00 | |
BJ TOTAL (I) | 1 076 565.00 | 1 076 565.00 | 1 076 565.00 | |
BZ Other receivables | 20 996.00 | 20 996.00 | 20 996.00 | |
CD Marketable securities | 50 000.00 | 50 000.00 | 50 000.00 | |
CF Cash and cash equivalents | 98.00 | 98.00 | 98.00 | |
CJ TOTAL (II) | 71 094.00 | 71 094.00 | 71 094.00 | |
CO Grand total (0 to V) | 1 147 659.00 | 1 147 659.00 | 1 147 659.00 | |
CU Other investments | 940 258.00 | 940 258.00 | 940 258.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 448 455.00 | 448 455.00 | 448 455.00 | |
DD Legal reserve (1) | 17 398.00 | 12 417.00 | 17 398.00 | |
DG Other reserves | 279 717.00 | 211 073.00 | 279 717.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 100 540.00 | 99 626.00 | 100 540.00 | |
DL TOTAL (I) | 846 111.00 | 771 571.00 | 846 111.00 | |
DU Loans and Debts from Credit Institutions (3) | 287 596.00 | 326 848.00 | 287 596.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 11 191.00 | 6 419.00 | 11 191.00 | |
DX Trade payables and related accounts | 2 524.00 | 1 744.00 | 2 524.00 | |
EA Other liabilities | 237.00 | 237.00 | ||
EC TOTAL (IV) | 301 548.00 | 335 011.00 | 301 548.00 | |
EE Grand total (I to V) | 1 147 659.00 | 1 106 582.00 | 1 147 659.00 | |
EG Accrued income and payables due within one year | 54 014.00 | 47 235.00 | 54 014.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FW Other purchases and external expenses | 9 271.00 | |||
FX Taxes, duties, and similar payments | 151.00 | |||
GF Total Operating Expenses (II) | 9 422.00 | |||
GG - OPERATING RESULT (I - II) | -9 422.00 | |||
GJ Financial income from other securities and fixed asset receivables | 112 676.00 | |||
GL Other interest and similar income | 188.00 | |||
GP Total financial income (V) | 112 864.00 | |||
GR Interest and similar expenses | 7 181.00 | |||
GU Total financial expenses (VI) | 7 181.00 | |||
GV - FINANCIAL INCOME (V - VI) | 105 683.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | 96 261.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HK Income tax | -4 279.00 | -2 657.00 | -4 279.00 | |
HL TOTAL REVENUE (I + III + V + VII) | 112 864.00 | 107 392.00 | 112 864.00 | |
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 12 324.00 | 7 767.00 | 12 324.00 | |
HN PROFIT OR LOSS (Total revenue - Total expenses) | 100 540.00 | 99 626.00 | 100 540.00 | |
